Genetic test announced for suicidal ideation in patients using antidepressant drugs
A new genetic test, Mark-C, has been announced to identify patients at risk of suicidal ideation when prescribed antidepressant drugs. The test is expected to help reduce suicide rates among U.S. youth and make antidepressant medication safer for patients worldwide.